News & Events

Jan 19, 2022

Press Releases

ViaCyte Strengthens Management Team with Appointment of Alyssa Levin as Chief Financial Officer and Addition of Lisa Porter, MD, to the Board of Directors

Ms. Levin is a seasoned CFO executive specializing in biotechnology corporate finance with broad expertise in accounting, investor relations, operations and strategy – Dr. Porter has over 20 years of drug development expertise leading to successful NDA and sNDA product approvals for metabolic diseases – SAN DIEGO, January 19, 2022 – ViaCyte, Inc., a clinical-stage […]

Read More

Sign up for updates

To have our press releases and major updates sent to you, please provide your name and email address.